Mechanomind
Digital Pathology AI for Cancer Diagnostics
Foreign StartupMechanomind is a foreign startup in the Health Tech & Life Sciences sector, established in 2017. Digital Pathology AI for Cancer Diagnostics. Core technologies: Artificial Intelligence.
The company follows a B2B business model.
- ModelB2B
- Last RoundUndisclosed
What does Mechanomind do?
Mechanomind aims to bring Artificial Intelligence (AI) to cancer care. Our goal is to transform the pathology by equipping pathologists with the advanced AI tools that help them to overcome todays challenges and fight cancer more effectively. Together we will ensure timely, affordable and best in quality care for a millions of cancer patients. We use cutting edge AI algorithms based neural networks and have already achieved better accuracy than the average human pathologist.
What sector is Mechanomind in?
Mechanomind operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, with core technologies in Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Providers.